Literature DB >> 7947603

HDL and apolipoprotein A-I protect erythrocytes against the generation of procoagulant activity.

R M Epand1, A Stafford, B Leon, P E Lock, E M Tytler, J P Segrest, G M Anantharamaiah.   

Abstract

The appearance of anionic lipids on the extracellular surface of cells is required for the formation of the procoagulant complex that leads to the activation of prothrombin. Procoagulant activity would be expected to be inhibited by substances that stabilize the membrane structure and hence inhibit the transbilayer diffusion of phosphatidylserine from the cytoplasmic to the extracellular surface of the plasma membrane. The generation of procoagulant activity in human erythrocytes by A23187 and Ca2+ is inhibited by apolipoprotein A-I, its amphipathic peptide analogues, and high-density lipoprotein (HDL). These agents do not inhibit the Ca2+ loading of erythrocytes by A23187, nor do they inhibit the activation of prothrombin once the cells have been incubated at 37 degrees C with A23187 and Ca2+. Transbilayer diffusion of fluorescently labeled phosphatidylserine is inhibited by apolipoprotein A-I. These findings indicate that class A amphipathic helixes as well as lipoprotein particles and liposomes inhibit the transbilayer diffusion of phospholipids and procoagulant activity. This activity may contribute to the protective role of HDL against arteriosclerosis and thrombosis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7947603     DOI: 10.1161/01.atv.14.11.1775

Source DB:  PubMed          Journal:  Arterioscler Thromb        ISSN: 1049-8834


  17 in total

Review 1.  Low high-density lipoprotein cholesterol: physiological background, clinical importance and drug treatment.

Authors:  Martin Hersberger; Arnold von Eckardstein
Journal:  Drugs       Date:  2003       Impact factor: 9.546

2.  Plasma levels of high-density lipoprotein cholesterol and outcomes in pulmonary arterial hypertension.

Authors:  Gustavo A Heresi; Metin Aytekin; Jennie Newman; Joseph DiDonato; Raed A Dweik
Journal:  Am J Respir Crit Care Med       Date:  2010-05-06       Impact factor: 21.405

Review 3.  Occlusive vascular diseases in oral contraceptive users. Epidemiology, pathology and mechanisms.

Authors:  I F Godsland; U Winkler; O Lidegaard; D Crook
Journal:  Drugs       Date:  2000-10       Impact factor: 9.546

4.  Correlation between the extent of coronary atherosclerosis and lipid profile.

Authors:  Janusz Tarchalski; Przemysław Guzik; Henryk Wysocki
Journal:  Mol Cell Biochem       Date:  2003-04       Impact factor: 3.396

5.  Primary Low Level of High-Density Lipoprotein Cholesterol and Risks of Coronary Heart Disease, Cardiovascular Disease, and Death: Results From the Multi-Ethnic Study of Atherosclerosis.

Authors:  Haitham M Ahmed; Michael Miller; Khurram Nasir; John W McEvoy; David Herrington; Roger S Blumenthal; Michael J Blaha
Journal:  Am J Epidemiol       Date:  2016-04-18       Impact factor: 4.897

Review 6.  Cellular cholesterol homeostasis in vascular endothelial cells.

Authors:  Hajj Hassan Hassan; Maxime Denis; Larbi Krimbou; Michel Marcil; Jacques Genest
Journal:  Can J Cardiol       Date:  2006-02       Impact factor: 5.223

7.  Proteomic analysis of swine serum following highly virulent classical swine fever virus infection.

Authors:  Jin-fu Sun; Zi-xue Shi; Huan-cheng Guo; Su Li; Chang-chun Tu
Journal:  Virol J       Date:  2011-03-08       Impact factor: 4.099

Review 8.  Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management.

Authors:  M John Chapman; Henry N Ginsberg; Pierre Amarenco; Felicita Andreotti; Jan Borén; Alberico L Catapano; Olivier S Descamps; Edward Fisher; Petri T Kovanen; Jan Albert Kuivenhoven; Philippe Lesnik; Luis Masana; Børge G Nordestgaard; Kausik K Ray; Zeljko Reiner; Marja-Riitta Taskinen; Lale Tokgözoglu; Anne Tybjærg-Hansen; Gerald F Watts
Journal:  Eur Heart J       Date:  2011-04-29       Impact factor: 29.983

Review 9.  Molecular mechanisms responsible for the antiinflammatory and protective effect of HDL on the endothelium.

Authors:  Giuseppe D Norata; Alberico L Catapano
Journal:  Vasc Health Risk Manag       Date:  2005

10.  Non-high density lipoprotein cholesterol versus low density lipoprotein cholesterol as a discriminating factor for myocardial infarction.

Authors:  Manoj Sigdel; Binod Kumar Yadav; Prajwal Gyawali; Prashant Regmi; Sushil Baral; Shyam Raj Regmi; Bharat Jha
Journal:  BMC Res Notes       Date:  2012-11-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.